Risk Factor Management in Atrial Fibrillation

被引：96

作者：

Brandes, Axel ^{[1
]}

Smit, Marcelle D. ^{[2
]}

Bao Oanh Nguyen ^{[2
]}

Rienstra, Michiel ^{[2
]}

Van Gelder, Isabelle C. ^{[1
,2
]}

机构：

[1] Univ Southern Denmark, Odense Univ Hosp, Dept Cardiol, Cardiol Res Unit, Odense, Denmark

[2] Univ Groningen, Univ Med Ctr Groningen, Thoraxctr, Groningen, Netherlands

来源：

ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW | 2018年 / 7卷 / 02期

关键词：

Atrial fibrillation; risk factors; lifestyle modification; prevention; integrated management;

D O I：

10.15420/aer.2018.18.2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Atrial fibrillation (AF) is the most common clinical arrhythmia and is associated with increased morbidity and mortality. There is growing evidence that numerous cardiovascular diseases and risk factors are associated with incident AF and that lone AF is rare. Beyond oral anticoagulant therapy, rate and rhythm control, therapy targeting risk factors and underlying conditions is an emerging AF management strategy that warrants better implementation in clinical practice. This review describes current evidence regarding the association between known modifiable risk factors and underlying conditions and the development and progression of AF. It discusses evidence for the early management of underlying conditions to improve AF outcomes. It also provides perspective on the implementation of tailored AF management in daily clinical practice.

引用

页码：118 / 127

页数：10

共 176 条

[21] A Clinical Risk Score for Atrial Fibrillation in a Biracial Prospective Cohort (from the Atherosclerosis Risk In Communities [ARIC] Study) [J].

Chamberlain, Alanna M. ;

Agarwal, Sunil K. ;

Folsom, Aaron R. ;

Soliman, Elsayed Z. ;

Chambless, Lloyd E. ;

Crow, Richard ;

Ambrose, Marietta ;

Alonso, Alvaro .

AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (01) :85-91

[22] Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies [J].

Chang, Shang-Hung ;

Wu, Lung-Sheng ;

Chiou, Meng-Jiun ;

Liu, Jia-Rou ;

Yu, Kuang-Hui ;

Kuo, Chang-Fu ;

Wen, Ming-Shien ;

Chen, Wei-Jan ;

Yeh, Yung-Hsin ;

See, Lai-Chu .

CARDIOVASCULAR DIABETOLOGY, 2014, 13

[23] CHADS2 score and risk of new-onset atrial fibrillation: A nationwide cohort study in Taiwan [J].

Chao, Tze-Fan ;

Liu, Chia-Jen ;

Chen, Su-Jung ;

Wang, Kang-Ling ;

Lin, Yenn-Jiang ;

Chang, Shih-Lin ;

Lo, Li-Wei ;

Hu, Yu-Feng ;

Tuan, Ta-Chuan ;

Wu, Tsu-Juey ;

Chen, Tzeng-Ji ;

Chen, Shih-Ann .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) :1360-1363

[24] Worldwide Epidemiology of Atrial Fibrillation A Global Burden of Disease 2010 Study [J].

Chugh, Sumeet S. ;

Havmoeller, Rasmus ;

Narayanan, Kumar ;

Singh, David ;

Rienstra, Michiel ;

Benjamin, Emelia J. ;

Gillum, Richard F. ;

Kim, Young-Hoon ;

McAnulty, John H. ;

Zheng, Zhi-Jie ;

Forouzanfar, Mohammad H. ;

Naghavi, Mohsen ;

Mensah, George A. ;

Ezzati, Majid ;

Murray, Christopher J. L. .

CIRCULATION, 2014, 129 (08) :837-847

[25] Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the US Adult Population [J].

Colilla, Susan ;

Crow, Ann ;

Petkun, William ;

Singer, Daniel E. ;

Simon, Teresa ;

Liu, Xianchen .

AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (08) :1142-1147

[26] Alcohol Consumption and Risk of Incident Atrial Fibrillation in Women [J].

Conen, David ;

Tedrow, Usha B. ;

Cook, Nancy R. ;

Moorthy, M. V. ;

Buring, Julie E. ;

Albert, Christine M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (21) :2489-2496

[27] Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode [J].

Cosio, Francisco G. ;

Aliot, Etienne ;

Botto, Giovanni Luca ;

Heidbuchel, Hein ;

Geller, Christoph Johan ;

Kirchhof, Paulus ;

De Haro, Jean-Claude ;

Frank, Robert ;

Villacastin, Julian Perez ;

Vijgen, Johan ;

Crijns, Harry .

EUROPACE, 2008, 10 (01) :21-27

[28] Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol [J].

Dahlöf, B ;

Devereux, RB ;

Kjeldsen, SE ;

Julius, S ;

Beevers, G ;

de Faire, U ;

Fyhrquist, F ;

Ibsen, H ;

Kristiansson, K ;

Lederballe-Pedersen, O ;

Lindholm, LH ;

Nieminen, MS ;

Omvik, P ;

Oparil, S ;

Wedel, H .

LANCET, 2002, 359 (9311) :995-1003

[29] Association Between Atrial Fibrillation and Dementia in the General Population [J].

de Bruijn, Renee F. A. G. ;

Heeringa, Jan ;

Wolters, Frank J. ;

Franco, Oscar H. ;

Stricker, Bruno H. C. ;

Hofman, Albert ;

Koudstaal, Peter J. ;

Ikram, M. Arfan .

JAMA NEUROLOGY, 2015, 72 (11) :1288-1294

[30] Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: Clinical correlates and the effect of rhythm-control therapy [J].

De Vos, Cees B. ;

Breithardt, Guenter ;

Camm, A. John ;

Dorian, Paul ;

Kowey, Peter R. ;

Le Heuzey, Jean-Yves ;

Naditch-Brule, Lisa ;

Prystowsky, Eric N. ;

Schwartz, Peter J. ;

Torp-Pedersen, Christian ;

Weintraub, William S. ;

Crijns, Harry J. .

AMERICAN HEART JOURNAL, 2012, 163 (05) :887-893

← 1 2 3 4 5 6 7 8 9 10 →